Dafna Yahav
-
- Antibiotic Use and Resistance 29
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria 32
- Microbiology top 0.5%
- Clinical Biochemistry top 0.5%
- Bacterial Identification and Susceptibility Testing 32
- Infectious Diseases top 1%
- Antimicrobial Resistance in Staphylococcus 19
- COVID-19 Clinical Research Studies 18
- SARS-CoV-2 and COVID-19 Research 17
-
- Antibiotics Pharmacokinetics and Efficacy 28
-
- Urinary Tract Infections Management 17
- Co-authors
- Mical PaulLeonard LeiboviciJihad BisharaNoa Eliakim‐RazAbigail FraserAdi LadorElad GoldbergBenaya Rozen‐Zvi
- Journals
- Clinical Microbiology and Infection (37 papers)European Journal of Clinical Microbiology & Infectious Diseases (12 papers)Journal of Antimicrobial Chemotherapy (12 papers)
- Partner nations
- IsraelUnited StatesItaly
In The Last Decade
Dafna Yahav
188 papers receiving 5.4k citations
Hit Papers
Peers
Comparison fields: 5 of 158
- Applied Microbiology and Biotechnology 645
- Molecular Medicine 1.3k
- Microbiology 110
- Clinical Biochemistry 641
- Infectious Diseases 1.6k
Countries citing papers authored by Dafna Yahav
This map shows the geographic impact of Dafna Yahav's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dafna Yahav with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dafna Yahav more than expected).
Fields of papers citing papers by Dafna Yahav
This network shows the impact of papers produced by Dafna Yahav. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dafna Yahav. The network helps show where Dafna Yahav may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dafna Yahav, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 0 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 0 | |
| 10 | 2023 | 12 | |
| 11 | 2023 | 3 | |
| 12 | 2022 | 6 | |
| 13 | 2022 | 35 | |
| 14 | 2021 | 1 | |
| 15 | 2021 | 6 | |
| 16 | 2021 | 11 | |
| 17 | New β-Lactam–β-Lactamase Inhibitor Combinationsbreakdown → | 2020 | 362 |
| 18 | 2020 | 1 | |
| 19 | 2019 | 13 | |
| 20 | 2019 | 3 |
About Dafna Yahav
Dafna Yahav is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Clinical Biochemistry, having authored 207 papers that have together received 5.5k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (32 papers), Bacterial Identification and Susceptibility Testing (32 papers), Antibiotic Use and Resistance (29 papers), Antibiotics Pharmacokinetics and Efficacy (28 papers), Antimicrobial Resistance in Staphylococcus (19 papers), COVID-19 Clinical Research Studies (18 papers), Urinary Tract Infections Management (17 papers) and SARS-CoV-2 and COVID-19 Research (17 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (645 citations), Molecular Medicine (1.3k citations) and Microbiology (110 citations). Dafna Yahav has collaborated with scholars based in Israel, United States and Italy. Frequent co-authors include Mical Paul, Leonard Leibovici, Jihad Bishara, Noa Eliakim‐Raz, Abigail Fraser, Adi Lador, Elad Goldberg, Benaya Rozen‐Zvi, Christian G. Giske and Henrietta Abodakpi. Their work appears in journals such as Clinical Microbiology and Infection, European Journal of Clinical Microbiology & Infectious Diseases, Journal of Antimicrobial Chemotherapy, Clinical Infectious Diseases and Cochrane Database of Systematic Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.